In May 2024, Biocon Limited, one of the global biopharmaceutical companies, entered into a semi-exclusive distribution and supply agreement with Medix, a specialty pharmaceutical company in Mexico, for the commercialization of generic Saxenda (Liraglutide) for chronic weight management
The author thanks Renata Novaes and Raquel C
Unavoidably, microglial TBK1-KO leads to focal microglial activation and both CD8 + and CD8 T cells infiltration in the basal ganglia (Lenoel et al., 2025)
"BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis"
But unlike brand-name GLP-1s, they arent Food and Drug Administration approved
We track your response against your own follow-up data rather than promising a fixed timeline